Claritev Corp (CTEV) 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2025. Claritev Corporation (formerly MultiPlan Corporation) is a technology, data, and insights company focused on improving transparency, affordability, and quality in the U.S. healthcare system. The company provides claims intelligence, network solutions, payment and revenue integrity, and data analytics solutions to payers, employers, and providers. In 2025, the company rebranded from MultiPlan to Claritev and launched "Vision 2030," a strategic transformation plan aimed at expanding its total addressable market and operational excellence.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | $965.4 million | $930.6 million | +3.7% |
| Net Loss (GAAP) | $(284.3) million | $(1,645.8) million | Improvement of $1.36 billion |
| Operating Income | $28.8 million | $(1,389.9) million | Turned profitable |
| Adjusted EBITDA | $602.6 million | $576.7 million | +4.5% |
| Adjusted EPS | $5.73 | $9.77 | -41.3% |
| Total Debt (Principal) | $4.61 billion | $4.57 billion | Minimal change |
| Cash & Equivalents | $16.8 million | $16.8 million | Flat |
| Operating Cash Flow | $117.3 million | $107.6 million | +9.0% |
Note: The 2024 Net Loss included a non-cash goodwill impairment charge of $1.49 billion. Excluding this, 2025 GAAP results show a significant reduction in losses compared to 2024.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 3.7% year-over-year, marking a return to growth after a decline in 2024. Network solutions revenue grew 11.6%, driven by a one-time $18.0 million revenue event from a new channel partner in the Property and Casualty line.
- Profitability: The company returned to operating profitability ($28.8 million) in 2025, compared to a significant operating loss in 2024. This was primarily due to the absence of the $1.49 billion goodwill impairment recorded in 2024.
- Expense Increases: General and Administrative (G&A) expenses rose 46.8% to $221.5 million. This increase was driven by $45.0 million in "Transformation costs" related to the Vision 2030 strategy and $16.9 million in antitrust-related legal costs.
- Debt Refinancing: In January 2025, the company completed a major refinancing transaction, exchanging older notes for new First Lien Term Loans and Notes with maturities extending to 2030 and 2031. This resulted in $8.0 million of transaction costs expensed in 2025.
Guidance, Outlook, and Risks
Outlook: Management has branded 2026 as "THE WAY UP," focusing on maintaining momentum from the 2025 turnaround. The company is executing "Vision 2030" to expand into new geographic markets (including the Middle East and North Africa) and new product lines (payer risk analytics, network transparency).
Key Risks & Contingencies:
- Client Concentration: Two clients accounted for 29.2% and 10.4% of total revenue in 2025. The loss of a major client could materially impact results.
- Internal Control Weaknesses: The company identified material weaknesses in internal control over financial reporting related to IT general controls (program change management and user access). Consequently, management concluded that internal controls were not effective as of December 31, 2025. A remediation plan is underway for 2026.
- Legal Proceedings: The company is a defendant in consolidated antitrust litigation alleging conspiracy with payers to suppress out-of-network reimbursements. Discovery is ongoing, and the company believes the claims are without merit.
- Debt Covenants: The company carries significant leverage ($4.6 billion). While currently in compliance, debt agreements contain restrictive covenants that could limit flexibility if financial metrics deteriorate.
Investor Verification Checklist
- Verify Internal Control Remediation: Monitor progress on the remediation of IT general control weaknesses identified in 2025 to ensure future financial reporting reliability.
- Assess Client Concentration Risk: Evaluate the stability of the top two clients (39.6% of revenue) and the potential impact of contract renewals or terminations.
- Review Antitrust Litigation Status: Track developments in the consolidated antitrust lawsuits, as adverse outcomes could result in significant liabilities or operational changes.
- Monitor Transformation Costs: Scrutinize the $45 million in 2025 transformation costs to ensure they yield the projected efficiency gains and revenue growth under Vision 2030.
- Debt Service Capacity: Analyze the company's ability to service $4.6 billion in debt, particularly given the high interest rates on variable-rate portions and the upcoming maturity of certain notes in 2030/2031.